Logo-jbp
J Biochem Phytomed. 2024;3(1): 8-13.
doi: 10.34172/jbp.2024.4
  Abstract View: 93
  PDF Download: 150

Mini Review

Exploring Dermatological Complications of Drugs Used in Acute Respiratory Syndrome Coronavirus 2 Treatment: A Mini Review

Marziyeh Soltani 1 ORCID logo, Fatemeh Abdi 2* ORCID logo, Somayeh Shahsavari 3 ORCID logo

1 Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
2 Institute of Medical Science, University of Toronto, Canada
3 Biotechnology and Medicinal Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran
*Corresponding Author: Email: f.abdi@mail.utoronto.ca

Abstract

The COVID-19 pandemic has presented unprecedented challenges to governments and populations worldwide, triggering a global health crisis within months. In response, international health research organizations have highlighted various effects of chemical therapies, including dermatological complications. This mini-review explores the dermatological effects of drugs used in the treatment of COVID-19. This study examines the skin manifestations resulting from standard chemical treatments administered during the COVID-19 pandemic. Keywords were cross-referenced across multiple databases, including Web of Science, Scopus, PubMed, SID, Magiran, and Google Scholar. Search terms included COVID-19, coronavirus, SARS-CoV-2, chemical effects, neurological effects, and pandemic-related cardiac complications. The review encompasses a range of pharmaceuticals used in the treatment of COVID-19, such as hydroxychloroquine, remdesivir, azithromycin, dexamethasone, ribavirin/interferon, intravenous immunoglobulin (IVIG), oseltamivir, losartan, magnesium sulfate, and vitamin D3. Our investigation identifies various cutaneous manifestations, including rash, erythema, and ulceration. Additionally, early-onset nocturnal symptoms, somnolence, dyspnea, edema, arrhythmias, scleroderma, and other adverse effects are associated with the standard pharmacotherapy used to manage COVID-19.

Please cite this paper as:

Soltani M, Abdi F, Shahsavari S. Exploring dermatological complications of drugs used in acute respiratory syndrome coronavirus 2 treatment: A mini review. Journal of Biochemicals and Phytomedicine. 2024; 3(1): 8-13. doi: 10.34172/jbp.2024.4.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 94

Your browser does not support the canvas element.


PDF Download: 150

Your browser does not support the canvas element.

Submitted: 07 Dec 2023
Revision: 01 Mar 2024
Accepted: 15 Mar 2024
ePublished: 30 Jun 2024
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)